Functional consequences phosphorylation barcoding/oligomerization CXCR4 and ACKR3

Early stage researcher 10 (ESR10) project
Supervision: Prof. Dr. Martine Smit, Dr. Marco Siderius
Host: Vrije Universiteit Amsterdam

I – Project proposal:


  1. Determine functional consequences of CXCR4/ACKR3 barcoding/oligomerization in signalling.
  2. Examine CXCR4/ACKR3 barcoding/dimer mutants using CRISPR/CAS.
  3. Characterisation multimeric CXCR4/ACKR3/RTK nanobodies.

Functional consequences of CXCR4/ACKR3 barcoding/oligomerization will be assessed using a range of established reporter gene assays, multiplex secretome analysis, high content imaging and oncogenic assays. CRISPR/CAS will be used to generate mutant and knock out cancer cell lines. Multivalent nanobodies will be used to modulate receptor complexes and signaling and effects assessed using ELISA, immunofluorescence, close proximity assays and (oncogenic) signaling assays.

Planned secondments:

QVQ Holding BV (Dr. Raimond Heukers)

Universitätsklinikum Jena (Prof. Carsten Hoffmann)


II – Requirement candidate:

Required diploma: MSc in molecular/biomedical Life Sciences, pharmaceutical sciences or related Life-Science degree.

Required expertise: biochemistry and molecular biology (DNA and protein level), cell culture, cellular signaling.

Recommended expertise: molecular cloning, biochemistry, SDS-PAGE, ELISA, FACS, cell based assays, fluorescence microscopy.

Key publications:

  1. De Groof TWM, et al, Smit MJ (2019) Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs. Mol Cell Endocrinol. 484:15-24.
  2. Bobkov V et al, Heukers R. Smit MJ (2018) Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions. Biochem Pharmacol. 158:413-424.
  3. Heukers R, et al, Smit MJ (2018) The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth. Oncogene 37:4110-4121.
  4. Maussang D, et al, Smit MJ (2013) Llama-derived single variable domains (Nanobodies) directed against CXCR7 reduce head and neck cancer cell growth in vivo. J Biol Chem 288:29562-72 and CXCR7 nanobody patent (WO2011117423 A1).
  5. Jähnichen S, et al, Smit MJ (2010) CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc Natl Acad Sci U S A. 107:20565-70.

For more information:
Prof. Dr. Martine Smit –

Dr. Marco Siderius –



Apply here

Follow us on

Great way to finish the week off with some #FCS measurements of CXCR4-expressing HEK cells at @UoNLifeSci 🔬 #FluorescenceFriday

Hello everyone!
I am Noemi Karsai and I’m the next in our #ESR introduction series. I’m #ESR11 and I’m originally from Hungary, currently doing my PhD at @UoNLifeSci @COMPARE_UoBUoN, UK.

The transatlantic ECI GPCR symposium #ECIGPCR is about to start, we are ready!! Thanks to the organizers for their excellent job gathering almost 500 people across the globe! @cyclic_Andreas @NicoleAPerry1 @BenderSci @DesislavaNeshe1

Hello 🙂
I am here to continue the series in which all #ESRs are presenting themselves. I am Viviana Marolda and I am in my first year of PhD. I am #ESR13, originally from Italy, and currently, I am working as a PhD student in @CBMSO_CSIC_UAM, at Universidad Autonoma de Madrid.

Hey twitter!
I am @DehanComez. I am taking over the Oncornet account for a while to start a series of all #ESRs writing about themselves and their projects. I am #ESR5, originally from Turkey and right now I am working as a PhD student in @COMPARE_UoBUoN , @UniofNottingham , UK.

New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond

ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function:

Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!

Load More

Contact details

Please contact us at:

ONCORNET Coordinator
VU University Amsterdam
The Netherlands